TYLER SNYDER: Open Payments
NPI 1396365532 · TOLEDO, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$561 in 16 payments from 7 companies in 2025. Trend: 2023 $122 · 2024 $155 · 2025 $561
Food & beverage: $561
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $247 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $140 |
| Axsome Therapeutics, Inc. | 1 | $87 |
| Otsuka America Pharmaceutical, Inc. | 2 | $29 |
| Indivior Inc. | 1 | $24 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $14 |
Products named: VRAYLAR, CAPLYTA, Auvelity, SUBLOCADE, COBENFY, ABILIFY ASIMTUFII, REXULTI.
Industry payments across OH — which companies pay providers there.
